Information:
Fel:
ID
13085
Beskrivning
Oral Collagen for Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00000401
Länk
https://clinicaltrials.gov/show/NCT00000401
Nyckelord
Versioner (1)
- 2016-01-15 2016-01-15 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
15 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT00000401
Eligibility Rheumatoid Arthritis NCT00000401
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00000401
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
rheumatoid arthritis
Item
clinically stable ra and unlikely to require adjustment of doses of dmards, nsaids, prednisone, or anti-tnfα therapies for the treatment phase of the study
boolean
C0003873 (UMLS CUI [1])
acr criteria
Item
meets american college of rheumatology (acr) 1988 revised criteria for ra
boolean
C0003873 (UMLS CUI [1])
onset of disease at age 16 or older
Item
onset of disease at age 16 or older
boolean
C0277793 (UMLS CUI [1])
onset of disease at least 3 months prior to enrollment
Item
onset of disease at least 3 months prior to enrollment
boolean
C0277793 (UMLS CUI [1])
pbmc - ifnγ - α1(ii)/pbs stimulation index
Item
pbmc - ifnγ - α1(ii)/pbs stimulation index greater than or equal to 1.5 in 6 months prior to baseline visit
boolean
herbal drug
Item
agree to discontinue herbal remedies described in this protocol
boolean
C1360419 (UMLS CUI [1])
contraception
Item
agree to use acceptable forms of contraception
boolean
C0700589 (UMLS CUI [1])
participation in another clinical research study
Item
participation in another clinical research study involving the evaluation of another investigational drug within 90 days prior to study entry
boolean
C2348568 (UMLS CUI [1])
prednisone
Item
currently taking greater than 7.5 mg prednisone daily
boolean
C0032952 (UMLS CUI [1])
intra-articular corticosteroid injections
Item
intra-articular corticosteroid injections within 30 days prior to study entry
boolean
C2064783 (UMLS CUI [1])
concurrent serious medical condition which, in the opinion of the investigator, makes the patient inappropriate for the study
Item
concurrent serious medical condition which, in the opinion of the investigator, makes the patient inappropriate for the study
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
beef allergy
Item
beef allergy
boolean
C0020517 (UMLS CUI [1,1])
C0452849 (UMLS CUI [1,2])
C0452849 (UMLS CUI [1,2])
fish oil
Item
use of fish oil within 4 weeks of study entry
boolean
C0556145 (UMLS CUI [1])
auranofin or cyclophosphamide
Item
previous use of auranofin or cyclophosphamide (all other dmards are allowed)
boolean
C0004320 (UMLS CUI [1])
C0010583 (UMLS CUI [2])
C0010583 (UMLS CUI [2])
stem cell transplantation
Item
previous autologous or heterologous stem cell transplantation
boolean
C1504389 (UMLS CUI [1])
malignancy
Item
active malignancy or past treatment consisting of antineoplastic drugs or total lymphoid irradiation
boolean
C0006826 (UMLS CUI [1])
citrus juice
Item
intolerance to citrus juices or colorless carbonated beverages
boolean
C0020517 (UMLS CUI [1,1])
C2347777 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0007025 (UMLS CUI [2,2])
C2347777 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0007025 (UMLS CUI [2,2])